120 related articles for article (PubMed ID: 9010562)
21. Antigenic activity of nonpollen parts (leaves and stems) of allergenic plants (Parietaria judaica and Dactylis glomerata).
D'Amato G; De Palma R; Verga A; Martucci P; Liccardi G; Lobefalo G
Ann Allergy; 1991 Oct; 67(4):421-4. PubMed ID: 1952298
[TBL] [Abstract][Full Text] [Related]
22. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
[TBL] [Abstract][Full Text] [Related]
23. A multicenter trial of specific local nasal immunotherapy.
Motta G; Passali D; De Vincentiis I; Ottaviani A; Maurizi M; Sartoris A; Pallestrini E; Motta S; Salzano FA
Laryngoscope; 2000 Jan; 110(1):132-9. PubMed ID: 10646729
[TBL] [Abstract][Full Text] [Related]
24. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
26. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
[TBL] [Abstract][Full Text] [Related]
27. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
Paranos S; Petrović S; Vojović I
Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study.
Tari MG; Mancino M; Ghezzi E; Frank E; Cromwell O
Allergy; 1997 Jan; 52(1):65-74. PubMed ID: 9062631
[TBL] [Abstract][Full Text] [Related]
29. Effect of birch pollen-specific immunotherapy on birch pollen-related hazelnut allergy.
van Hoffen E; Peeters KA; van Neerven RJ; van der Tas CW; Zuidmeer L; van Ieperen-van Dijk AG; Bruijnzeel-Koomen CA; Knol EF; van Ree R; Knulst AC
J Allergy Clin Immunol; 2011 Jan; 127(1):100-1, 101.e1-3. PubMed ID: 20933256
[No Abstract] [Full Text] [Related]
30. Allergen-specific immunotherapy with recombinant grass pollen allergens.
Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
[TBL] [Abstract][Full Text] [Related]
31. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
Hordijk GJ; Antvelink JB; Luwema RA
Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
[TBL] [Abstract][Full Text] [Related]
32. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica.
García-Sellés J; Pascual A; Funes E; Pagán JA; López JD; Negro JM; Hernández J
Allergol Immunopathol (Madr); 2003; 31(2):63-9. PubMed ID: 12646120
[TBL] [Abstract][Full Text] [Related]
34. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
35. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response.
Rondón C; Doña I; López S; Campo P; Romero JJ; Torres MJ; Mayorga C; Blanca M
Allergy; 2008 Oct; 63(10):1352-8. PubMed ID: 18782115
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin G4-antibodies to rBet v 1 and risk of sensitization and atopic disease in the child.
Kihlström A; Hedlin G; Pershagen G; Troye-Blomberg M; Härfast B; Lilja G
Clin Exp Allergy; 2005 Dec; 35(12):1542-9. PubMed ID: 16393319
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects.
Passalacqua G; Albano M; Pronzato C; Riccio AM; Scordamaglia A; Falagiani P; Canonica GW
Clin Exp Allergy; 1997 Aug; 27(8):904-8. PubMed ID: 9291287
[TBL] [Abstract][Full Text] [Related]
39. Double-blind placebo controlled specific immunotherapy with mixed Cupressaceae taxodiaceae pollens in respiratory allergy to Cupressus sempervirens.
Ariano R; Panzani RC; Augeri G
Allergol Immunopathol (Madr); 1997; 25(1):23-9. PubMed ID: 9111873
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy with Alpare in patients with respiratory allergy to Parietaria pollen: a two year double-blind placebo-controlled study.
D'Amato G; Kordash TR; Liccardi G; Lobefalo G; Cazzola M; Freshwater LL
Clin Exp Allergy; 1995 Feb; 25(2):149-58. PubMed ID: 7750007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
